3 unknown. 3 Phase 3, 2 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 3 | Unknown 3 |
| Phase 2 | 2 | Unknown 2 |
Follow PTSD: new trials by email Literature Review of PTSD trials Research Report on PTSD
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Glecaprevir/Pibrentasvir for Post-traumatic Stress Disorder Glecaprevir/pibrentasvir, Placebo - PTSD | Phase 2 / Phase 3 | Unknown | White River Junction Veterans Affairs Medical Center | 92 | 2023-12-18 | 2025-04-24 |
| Transcendental Meditation and PTSD TM, PCT - Ptsd, Depressive Symptoms | Phase 3 | Unknown | David Lynch Foundation | 450 | 2021-10-01 | 2021-04-22 |
| Psycho-educational Tool to Prevent Psychological Sequelae Following Paediatric Intensive Care Unit Admission Age-specific information booklet and targeted telephone call - PTSD | Phase 2 / Phase 3 | Unknown | Imperial College Healthcare NHS Trust | 288 | 2021-07-01 | 2022-03-24 |
Stress Disorders, Post-Traumatic (3) · Alcohol Drinking (1) · Depression (1) · Hepatitis C (1) · Suicidal Ideation (1)
Mental Disorders (3) · Stress Disorders, Traumatic (3) · Trauma and Stressor Related Disorders (3) · Behavior (1) · Behavioral Symptoms (1) · Blood-Borne Infections (1) · Communicable Diseases (1) · Digestive System Diseases (1) · Drinking Behavior (1) · Flaviviridae Infections (1) · Hepatitis (1) · Hepatitis, Viral, Human (1) · Infections (1) · Liver Diseases (1) · RNA Virus Infections (1)
glecaprevir and pibrentasvir (1)
David Lynch Foundation (1) · Imperial College Healthcare NHS Trust (1) · White River Junction Veterans Affairs Medical Center (1)
United Kingdom (1) · United States (1)
Bradley V Watts, MD, MPH (1) · Simon Nadel, MBBS (1) · Thomas Rutledge, PhD (1)